Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.
about
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the TrendPulmonary-intestinal cross-talk in mucosal inflammatory diseaseTele-monitoring reduces exacerbation of COPD in the context of climate change--a randomized controlled trial.Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settingsThe pharmacotherapy preferred by doctors in treatment of patients diagnosed with asthma or chronic obstructive pulmonary disease or allergic rhinitis and concomitant diseases: an epidemiological analysisChronic obstructive pulmonary disease is independently associated with hypertension in men: A survey design analysis using nationwide survey data.Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.Right heart functional changes in the acute, hypercapnic exacerbations of COPD.Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia.The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy.Continuity of care for elderly patients with diabetes mellitus, hypertension, asthma, and chronic obstructive pulmonary disease in KoreaThe empirical foundations of telemedicine interventions for chronic disease management.Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional studyComorbidity in chronic obstructive pulmonary disease. Related to disease severity?Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: the Rancho Bernardo study.Development of a self-treatment approach for patients with COPD and comorbidities: an ongoing learning process.A simplified score to quantify comorbidity in COPDAssessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease.Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary diseaseAppropriateness and acceptability of a Tele-Yoga intervention for people with heart failure and chronic obstructive pulmonary disease: qualitative findings from a controlled pilot studyComorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary diseaseManagement of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.COPD Hospitalization Risk Increased with Distinct Patterns of Multiple Systems Comorbidities Unveiled by Network Modeling.Gastro-oesophageal reflux disease increases the risk of intensive care unit admittance and mechanical ventilation use among patients with chronic obstructive pulmonary disease: a nationwide population-based cohort studyThe validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease.Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008.Palliative care provision for patients with chronic obstructive pulmonary disease.Frequency, cost, and risk factors of readmissions among severe sepsis survivors.Prognosis in patients having chronic obstructive pulmonary disease with significant coronary artery lesion anginaUrinary albumin-creatinine ratio, estimated glomerular filtration rate, and all-cause mortality among US adults with obstructive lung function.Prevalence of airflow obstruction in patients with stable systolic heart failure.
P2860
Q27026708-D63B1CA7-F20A-4C6A-BC22-DBDF2563CB03Q27693862-01E8DF3C-296A-4D01-9220-2CB452674FE6Q30699173-1F2FCF68-A120-4C65-A94C-6A532DB89DBFQ30989356-E7E90CEF-019F-4F97-8738-9E0D792C7621Q33532293-6D09C133-A97F-4AD3-AFAA-FC259DCFCF23Q33645873-C6008A7D-5182-4384-82A6-7AC4CE0C1280Q33672615-DA7243CD-E76C-4A9D-8DA1-84E8EFDF6588Q33689926-33FA2A5F-68BA-4E49-A783-FCCC5308E2D2Q33709357-E7901001-5844-4415-8311-E57EB6D91160Q33790733-61C53D3B-791D-4335-AD2E-9A05A4036C93Q33876337-A2D42CE7-58D5-449A-B35A-9ECD7539B6B4Q33933904-7BCD3044-C66D-4CA7-8C95-0E434BE33411Q33966009-B6AD3128-1392-43C8-A909-269225050A4AQ33994968-A86C863D-84AE-477B-AF29-140EEDF576F7Q34036358-AD8D23B3-3A50-4BA1-8219-19C7905D66A5Q34073709-D3CCFCCC-D895-4BEA-975E-2F5CB6DEF504Q34103854-50670CBE-B469-4090-8045-E37C50965D0AQ34105094-3DFD1692-B960-41AA-BFD8-CFF4ABBAFBD8Q34303093-7375BA0D-6D76-43EC-957D-BB5F8D3228B8Q34549923-0EF29EE5-8358-4A9D-A2C8-6C8F68E25D70Q34564347-BEF93CC0-D8B9-4175-B09E-B45873D42995Q34626048-43B4405C-5A83-4CEF-A335-4254D84C64B6Q34628620-AD50F61A-6349-42E3-A8C8-EDA93A25326CQ34712570-757A8A69-2FED-4786-853E-53DA6B7E4C15Q34943351-6EAD52EB-4B95-4E4E-900A-7131CF2CDE3CQ34986952-1343D2DE-E6E8-458D-A9A5-F0641A15FC20Q35074049-465E8AD9-E6A6-4B18-8483-B3C9F3700AC4Q35087187-1E04F3DE-5C92-4914-B693-C0AA7E5ED05FQ35168749-75CA360D-A7FB-4FBE-9914-55B7909E8AD4Q35225129-856D879C-4653-4917-9703-FAC486BAB326Q35570302-5CBDF5E9-620F-4AB9-AB45-897A537C32D8Q35575807-0065EFBB-B0AB-420B-A705-5A9FBC64C06DQ35651848-5916B0A4-0A50-4096-AD67-1938B4C17140Q35685421-AD103718-09A6-440C-86BF-1237A7B40195Q35695265-136D870F-AD04-4471-8107-F4E03838171DQ35750714-D769237B-CAC9-49B5-9ECD-8892EC7C7D53Q35776374-BD039D8D-042F-40D3-9A88-E064227ADE76Q36025242-753F596B-DA6A-4F02-829E-4544277B4F1AQ36087862-E31B5E7A-C6F4-4062-86AA-194B76E1A101Q36243275-C4DC2CDB-0703-4D45-B834-ED451A5A6D47
P2860
Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Comorbidity and mortality in C ...... e United States, 1979 to 2001.
@en
Comorbidity and mortality in C ...... e United States, 1979 to 2001.
@nl
type
label
Comorbidity and mortality in C ...... e United States, 1979 to 2001.
@en
Comorbidity and mortality in C ...... e United States, 1979 to 2001.
@nl
prefLabel
Comorbidity and mortality in C ...... e United States, 1979 to 2001.
@en
Comorbidity and mortality in C ...... e United States, 1979 to 2001.
@nl
P356
P1433
P1476
Comorbidity and mortality in C ...... e United States, 1979 to 2001.
@en
P2093
Fernando Holguin
Stephen C Redd
P304
P356
10.1378/CHEST.128.4.2005
P407
P577
2005-10-01T00:00:00Z